EXAS vs FHI · rev $2.76B vs P/E 11, rev $981.7M
EXACT Sciences Corporation (EXAS) versus Federated Investors Inc B (FHI) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Federated Investors Inc B (FHI) is a asset management company listed on US.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported FHI revenue for 2026-06-30 was $981.7M. Net income was $200.7M. FHI currently screens at market cap $4.33B and trailing P/E 11.1.
EXAS currently screens at market cap $20.03B. FHI currently screens at market cap $4.33B and trailing P/E 11.1.
Not investment advice. Open the EXAS and FHI stock pages for the full models.
Not investment advice.